19.14
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché HIMS Giù?
Forum
Previsione
Precedente Chiudi:
$19.84
Aprire:
$19.31
Volume 24 ore:
23.37M
Relative Volume:
0.72
Capitalizzazione di mercato:
$4.36B
Reddito:
$2.35B
Utile/perdita netta:
$128.37M
Rapporto P/E:
36.66
EPS:
0.5221
Flusso di cassa netto:
$57.42M
1 W Prestazione:
-8.25%
1M Prestazione:
+16.14%
6M Prestazione:
-66.93%
1 anno Prestazione:
-38.69%
Hims Hers Health Inc Stock (HIMS) Company Profile
Nome
Hims Hers Health Inc
Settore
Telefono
415-851-0195
Indirizzo
2269 CHESTNUT ST, SAN FRANCISCO
Compare HIMS vs TAK, ZTS, HLN, TEVA, UTHR
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
HIMS
Hims Hers Health Inc
|
19.14 | 4.36B | 2.35B | 128.37M | 57.42M | 0.5221 |
|
TAK
Takeda Pharmaceutical Co Adr
|
18.74 | 59.20B | 29.85B | 776.90M | 4.35B | 0.2408 |
|
ZTS
Zoetis Inc
|
117.94 | 49.79B | 9.47B | 2.67B | 2.28B | 6.0218 |
|
HLN
Haleon Plc Adr
|
9.93 | 44.27B | 14.54B | 2.22B | 2.58B | 0.4871 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
30.08 | 35.03B | 17.41B | 1.43B | 1.00B | 1.2182 |
|
UTHR
United Therapeutics Corp
|
564.81 | 24.75B | 3.18B | 1.33B | 1.04B | 27.90 |
Hims Hers Health Inc Stock (HIMS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-03-10 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2026-03-10 | Aggiornamento | Citigroup | Sell → Neutral |
| 2026-03-09 | Aggiornamento | Needham | Hold → Buy |
| 2026-02-24 | Downgrade | BTIG Research | Buy → Neutral |
| 2026-01-12 | Iniziato | Evercore ISI | In-line |
| 2025-12-09 | Iniziato | Barclays | Overweight |
| 2025-10-21 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2025-06-23 | Downgrade | Needham | Buy → Hold |
| 2025-06-04 | Reiterato | Needham | Buy |
| 2025-04-29 | Downgrade | TD Cowen | Buy → Hold |
| 2025-02-18 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2025-01-10 | Downgrade | Citigroup | Neutral → Sell |
| 2025-01-07 | Iniziato | BTIG Research | Buy |
| 2024-12-17 | Iniziato | Morgan Stanley | Overweight |
| 2024-11-14 | Downgrade | BofA Securities | Buy → Underperform |
| 2024-08-22 | Iniziato | Needham | Buy |
| 2024-08-09 | Downgrade | Imperial Capital | Outperform → In-line |
| 2024-05-22 | Downgrade | Citigroup | Buy → Neutral |
| 2024-04-16 | Downgrade | Jefferies | Buy → Hold |
| 2024-04-10 | Iniziato | Canaccord Genuity | Buy |
| 2024-02-28 | Aggiornamento | Imperial Capital | In-line → Outperform |
| 2024-02-26 | Iniziato | Leerink Partners | Market Perform |
| 2023-12-07 | Iniziato | Imperial Capital | In-line |
| 2023-07-28 | Iniziato | TD Cowen | Outperform |
| 2023-04-11 | Iniziato | Robert W. Baird | Neutral |
| 2023-02-09 | Aggiornamento | Jefferies | Hold → Buy |
| 2022-11-08 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2022-11-08 | Aggiornamento | SVB Leerink | Mkt Perform → Outperform |
| 2022-10-17 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2022-09-07 | Iniziato | Truist | Hold |
| 2022-07-15 | Iniziato | SVB Leerink | Underperform |
| 2022-04-14 | Iniziato | Guggenheim | Buy |
| 2022-04-01 | Ripresa | Credit Suisse | Outperform |
| 2022-03-10 | Iniziato | Deutsche Bank | Hold |
| 2021-12-02 | Iniziato | Jefferies | Hold |
| 2021-11-11 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2021-07-06 | Iniziato | BofA Securities | Neutral |
| 2021-05-20 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2021-04-21 | Iniziato | Truist | Hold |
| 2021-03-09 | Iniziato | Credit Suisse | Neutral |
| 2021-03-02 | Aggiornamento | Citigroup | Neutral → Buy |
| 2021-02-17 | Iniziato | Citigroup | Neutral |
| 2021-02-12 | Iniziato | Piper Sandler | Neutral |
| 2021-02-08 | Iniziato | Tigress Financial | Buy |
Mostra tutto
Hims Hers Health Inc Borsa (HIMS) Ultime notizie
Best Healthcare Stocks To Add to Your WatchlistApril 5th - marketbeat.com
Hims & Hers Health, Inc. (HIMS) stock price, news, quote and history - Yahoo Finance Singapore
Hims Data Breach Tests Trust As Valuation Gap Attracts Investors - Yahoo Finance
Novo partnership fuels long-term optimism for Hims & Hers Health, Inc. (HIMS) - MSN
Data Breach Alert: Edelson Lechtzin LLP Investigates Hims & Hers, Inc. Data Breach - GlobeNewswire Inc.
Data Breach Alert: Edelson Lechtzin LLP Investigates Hims & Hers, Inc. Data Breach - PR Newswire
Hims & Hers Health Faces Investor Lawsuit Over Alleged Misconduct - National Today
Hims & Hers Health Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Hims & Hers Health, Inc.HIMS - Business Wire
Hims & Hers hack: Telehealth company reports customer support system breach - The American Bazaar
Barclays raises PT on Hims & Hers Health (HIMS) stock - MSN
HIMS Stock Gains As FDA Reportedly Moves Toward Lifting Restrictions On Peptides - Stocktwits
Healthcare Stocks To Watch TodayApril 3rd - MarketBeat
Hims & Hers warns of data breach after Zendesk support ticket breach - BleepingComputer
Hims & Hers Health, Inc. (HIMS) Stock Price, News, Quote & History - Yahoo! Finance Canada
Hims and Hers reveal cyberattack — customer support system hacked and personal info stolen, here's what we know - TechRadar
Hims & Hers' Valuations Back To EarthRobust Monetization Trends Deserve Reiterated Buy - Seeking Alpha
Hims & Hers Health stock price forecast: sideways consolidation likely as HIMS falls 3.53% - Traders Union
Here is What to Know Beyond Why Hims & Hers Health, Inc. (HIMS) is a Trending Stock - Yahoo Finance
HIMS stock gains as FDA reportedly moves toward lifting restrictions on peptides - MSN
AI for investors - MLQ.ai
Security Breach and Trade Policy Fears Weigh on Hims & Hers Stock - AD HOC NEWS
Should You Buy Hims Stock Today? - theglobeandmail.com
Hims & Hers Health, Regeneron, Biogen, BioMarin Pharmaceutical, and Moderna Shares Are Falling, What You Need To Know - Yahoo Finance
Hims & Hers flags suspicious activity linked to third‑party customer service vendor - TradingView
Hims & Hers Data Breach Exposes Customer Service Records - Claim Depot
Building Better Health: AI as the Operating System for Care - Hims & Hers Newsroom
Broad selling pressure keeps Hims & Hers stock restrained after telehealth expansion news - Traders Union
Hims & Hers Health, Inc. (HIMS) Outperforms Broader Market: What You Need to Know - MSN
US FDA clarifies policies on compounding of GLP-1 medicines - Reuters
Hims & Hers Health Inc (HIMS) Stock Price, Trades & News - GuruFocus
HIMS Investors Have Opportunity to Join Hims & Hers Health, Inc. Fraud Investigation with the Schall Law Firm - GlobeNewswire
Hims & Hers Health Stock Short Interest Falls to 45.18% - Quiver Quantitative
-3.88% for Hims & Hers Health stock as oscillators give mixed signals near session low - Traders Union
Hims & Hers Stock Is Down 63% Over the Past 6 Months. Here’s Why the Valuation Still Looks Compelling - TIKR.com
Novo Partnership Fuels Long-Term Optimism for Hims & Hers Health, Inc. (HIMS) - Insider Monkey
Hims & Hers expands personalized digital healthcare platform - MSN
Hims & Hers Broadens Tailored Online Health Services Platform - Bitget
Hims & Hers Expands Personalized Digital Healthcare Platform - The Globe and Mail
Hims & Hers Health Inc (HIMS) Stock Price Up 6.42% on Mar 31 - GuruFocus
HIMS Gains as FDA Revisits Rules on Compounding Pharmacies - GuruFocus
Did Hims & Hers' Novo Nordisk GLP-1 Partnership Just Shift Hims & Hers Health's (HIMS) Investment Narrative? - Sahm
Hims Novo Nordisk GLP-1 Launch Ties Growth Story To Valuation Gap - simplywall.st
Hims & Hers Health, Inc. (HIMS) registers a bigger fall than the market: Important facts to note - MSN
HIMS Sees Moderate Bearish Sentiment Among Option Traders - GuruFocus
Hims & Hers Health, Inc. (HIMS) Registers a Bigger Fall Than the Market: Important Facts to Note - Yahoo Finance
Hims & Hers Health Options Spot-On: On March 30th, 88,151 Contracts Were Traded, With 1.15 Million Open Interest - Moomoo
Assessing Hims & Hers Health (HIMS) Valuation After A Sharp Pullback And Long Term Shareholder Gains - Sahm
HIMS stock in spotlight after Hims & Hers adds Novo’s GLP-1 treatments to its platform - MSN
Why (HIMS) Price Action Is Critical for Tactical Trading - Stock Traders Daily
Hims & Hers Health, Inc. (HIMS) Experiences a Sharper Decline Compared to the Overall Market: Key Points to Consider - bitget.com
Hims & Hers Health stock price forecast: persistent bearish setup as HIMS extends decline toward $18 - Traders Union
Hims Hers Health Inc Azioni (HIMS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):